[New compound NL-608 (a nutlin analog) induces apoptosis in human breast cancer MCF-7 cells]
Ya-Kun Ge1, Yuan-Xin Zhang, Yun-Peng Chen
1College of Environmental & Biological Engineering, Jilin Institute of Chemical Technology, Jilin 132022, China.
Objective:
To observe the effect of NL-608 (a nutlin analog) on apoptosis induction in human breast cancer MCF-7 cells in vitro, and investigate the relevant molecular mechanism.
Methods:
The effect of NL-608 on proliferation of MCF-7 cells was determined by MTT assay. The apoptosis in MCF-7 cells was determined by flow cytometry with annexin V-FITC and PI. The activity of caspase 3, caspase 8 and caspase 9 was determined with caspase activity assay kit and Western blot, and the proteins of Fas and FasL were determined by Western blot.
Results:
NL-608 showed a dose-dependent inhibitory effect on the proliferation of MCF-7 cells. It induced apoptosis in MCF-7 cells in a dose-dependent manner. The activity of caspase 3 and caspase 8 in MCF-7 cells was increased with the increasing concentration of NL-608, but caspase 9 had no changes. The proteins of Fas and FasL were increased in a dose-dependent manner.
Conclusion:
NL-608 induces apoptosis in MCF-7 cells in vitro through inducing caspase 3 activity and death receptor-mediated signal pathway.
Insights
NL-608, a nutlin analog, effectively inhibits human breast cancer MCF-7 cell proliferation and induces apoptosis. This occurs via increased caspase 3 activity and the Fas/FasL death receptor pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Human breast cancer remains a significant health concern, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms of apoptosis induction is crucial for developing targeted cancer treatments.
Purpose of the Study:
- To evaluate the anti-cancer effects of NL-608, a nutlin analog, on human breast cancer MCF-7 cells in vitro.
- To elucidate the molecular pathways involved in NL-608-induced apoptosis.
Main Methods:
- Cell proliferation was assessed using the MTT assay.
- Apoptosis was quantified via flow cytometry (Annexin V-FITC/PI staining).
- Caspase activity (caspase 3, 8, 9) and protein expression (Fas, FasL) were analyzed by Western blot and activity assay kits.
Main Results:
- NL-608 demonstrated a dose-dependent inhibition of MCF-7 cell proliferation.
- Apoptosis was induced in a dose-dependent manner, correlating with increased caspase 3 and caspase 8 activity.
- Fas and FasL protein levels were upregulated in response to NL-608 treatment, while caspase 9 activity remained unchanged.
Conclusions:
- NL-608 effectively induces apoptosis in human breast cancer MCF-7 cells.
- The mechanism involves activation of caspase 3 and the death receptor pathway (Fas/FasL).
